tiprankstipranks
Trending News
More News >
NRX Pharmaceuticals (NRXP)
NASDAQ:NRXP
US Market
Advertisement

NRX Pharmaceuticals (NRXP) Financial Statements

Compare
578 Followers

NRX Pharmaceuticals Financial Overview

NRX Pharmaceuticals's market cap is currently $87.24M. The company's EPS TTM is $-0.98; its P/E ratio is ―; NRX Pharmaceuticals is scheduled to report earnings on August 18, 2025, and the estimated EPS forecast is $0.02. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

NRX Pharmaceuticals Earnings and Revenue History

NRX Pharmaceuticals Debt to Assets

NRX Pharmaceuticals Cash Flow

NRX Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis